Literature DB >> 21607028

A new paradigm in the treatment of the cardiovascular disease continuum: focus on prevention.

S G Chrysant1.   

Abstract

The cardiovascular disease continuum (CVDC) is a sequence of cardiovascular events, which begins from a cluster of cardiovascular risk factors consisting of diabetes mellitus, dyslipidemia, hypertension, smoking and visceral obesity. If these factors are not intervened with early, they will, inexorably, progress to atherosclerosis, coronary artery disease, myocardial infarction, left ventricular hypertrophy, left ventricular dilatation leading to left ventricular diastolic or systolic dysfunction and eventually end stage heart failure and death. For this concise review, a Medline search of the English language literature between the years 2000 and 2009 was conducted and 33 pertinent publications were selected. Based on the evidence contained in these publications, it is possible that early intervention and treatment of the various cardiovascular risk factors, which initiate and perpetuate the CVDC, could prevent it or arrest its further progress. Therefore, this concise review will emphasize the early detection and treatment of the various cardiovascular risk factors, which initiate and perpetuate the CVDC.

Entities:  

Keywords:  cardiovascular disease continuum; diabetes mellitus; dyslipidemia; hypertension; obesity; review; smoking

Year:  2011        PMID: 21607028      PMCID: PMC3093150     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  39 in total

Review 1.  The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).

Authors:  Victor J Dzau; Elliott M Antman; Henry R Black; David L Hayes; JoAnn E Manson; Jorge Plutzky; Jeffrey J Popma; William Stevenson
Journal:  Circulation       Date:  2006-12-19       Impact factor: 29.690

Review 2.  Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis.

Authors:  Matthias W Lorenz; Hugh S Markus; Michiel L Bots; Maria Rosvall; Matthias Sitzer
Journal:  Circulation       Date:  2007-01-22       Impact factor: 29.690

Review 3.  The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome.

Authors:  Peter M Nilsson; Empar Lurbe; Stéphane Laurent
Journal:  J Hypertens       Date:  2008-06       Impact factor: 4.844

Review 4.  Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.

Authors:  John B Buse; Henry N Ginsberg; George L Bakris; Nathaniel G Clark; Fernando Costa; Robert Eckel; Vivian Fonseca; Hertzel C Gerstein; Scott Grundy; Richard W Nesto; Michael P Pignone; Jorge Plutzky; Daniel Porte; Rita Redberg; Kimberly F Stitzel; Neil J Stone
Journal:  Diabetes Care       Date:  2007-01       Impact factor: 19.112

5.  Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Authors:  Wayne Rosamond; Katherine Flegal; Gary Friday; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Michael Ho; Virginia Howard; Brett Kissela; Bret Kissela; Steven Kittner; Donald Lloyd-Jones; Mary McDermott; James Meigs; Claudia Moy; Graham Nichol; Christopher J O'Donnell; Veronique Roger; John Rumsfeld; Paul Sorlie; Julia Steinberger; Thomas Thom; Sylvia Wasserthiel-Smoller; Yuling Hong
Journal:  Circulation       Date:  2006-12-28       Impact factor: 29.690

6.  Feasibility of treating prehypertension with an angiotensin-receptor blocker.

Authors:  Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork
Journal:  N Engl J Med       Date:  2006-03-14       Impact factor: 91.245

7.  Depression: a predictor of smoking relapse in a 6-month follow-up after hospitalization for acute coronary syndrome.

Authors:  Glória Heloise Perez; José Carlos Nicolau; Bellkiss Wilma Romano; Ronaldo Laranjeira
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2008-02

8.  The association of pediatric low- and high-density lipoprotein cholesterol dyslipidemia classifications and change in dyslipidemia status with carotid intima-media thickness in adulthood evidence from the cardiovascular risk in Young Finns study, the Bogalusa Heart study, and the CDAH (Childhood Determinants of Adult Health) study.

Authors:  Costan G Magnussen; Alison Venn; Russell Thomson; Markus Juonala; Sathanur R Srinivasan; Jorma S A Viikari; Gerald S Berenson; Terence Dwyer; Olli T Raitakari
Journal:  J Am Coll Cardiol       Date:  2009-03-10       Impact factor: 24.094

Review 9.  Development of heart failure in recent hypertension trials.

Authors:  Giuliano Tocci; Sebastiano Sciarretta; Massimo Volpe
Journal:  J Hypertens       Date:  2008-07       Impact factor: 4.844

10.  The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.

Authors:  Stephan Lüders; Joachim Schrader; Jürgen Berger; Thomas Unger; Walter Zidek; Michael Böhm; Martin Middeke; Wolfgang Motz; Cornelia Lübcke; Andrea Gansz; Ludmer Brokamp; Roland E Schmieder; Peter Trenkwalder; Herrmann Haller; Peter Dominiak
Journal:  J Hypertens       Date:  2008-07       Impact factor: 4.844

View more
  6 in total

1.  Echocardiographic Characterization of Left Ventricular Structure, Function, and Coronary Flow in Neonate Mice.

Authors:  Shamim A K Chowdhury; Paola C Rosas
Journal:  J Vis Exp       Date:  2022-04-07       Impact factor: 1.424

Review 2.  Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders.

Authors:  Mohammad Hosein Farzaei; Amit Kumar Singh; Ramesh Kumar; Courtney R Croley; Abhay K Pandey; Ericsson Coy-Barrera; Jayanta Kumar Patra; Gitishree Das; Rout George Kerry; Giuseppe Annunziata; Gian Carlo Tenore; Haroon Khan; Matteo Micucci; Roberta Budriesi; Saeideh Momtaz; Seyed Mohammad Nabavi; Anupam Bishayee
Journal:  Int J Mol Sci       Date:  2019-10-08       Impact factor: 5.923

Review 3.  Developing a Sustainable Cardiovascular Disease Research Strategy in Tanzania Through Training: Leveraging From the East African Centre of Excellence in Cardiovascular Sciences Project.

Authors:  Pilly Chillo; Fredirick Mashili; Gideon Kwesigabo; Paschal Ruggajo; Appolinary Kamuhabwa
Journal:  Front Cardiovasc Med       Date:  2022-03-25

4.  Chinese Herbal Medicine Reduces the Risk of Heart Failure in Hypertensive Patients: A Nationwide, Retrospective, Cohort Study.

Authors:  Chun-Ting Liu; I-Ling Hung; Chung Y Hsu; Kai-Chieh Hu; Yung-Hsiang Chen; Ming-Yen Tsai
Journal:  Front Cardiovasc Med       Date:  2022-07-11

5.  Cymbopogon Proximus Essential Oil Protects Rats against Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis.

Authors:  Hassan N Althurwi; Maged S Abdel-Kader; Khalid M Alharthy; Mohamad Ayman Salkini; Faisal F Albaqami
Journal:  Molecules       Date:  2020-04-13       Impact factor: 4.411

Review 6.  Blood Pressure Sensors: Materials, Fabrication Methods, Performance Evaluations and Future Perspectives.

Authors:  Ahmed Al-Qatatsheh; Yosry Morsi; Ali Zavabeti; Ali Zolfagharian; Nisa Salim; Abbas Z Kouzani; Bobak Mosadegh; Saleh Gharaie
Journal:  Sensors (Basel)       Date:  2020-08-11       Impact factor: 3.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.